New cancer clinical trial: Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

Published on: November 28, 2018 at 12:00PM
Conditions:   Breast Cancer;   Neoplasm, Breast;   Breast Diseases
Interventions:   Drug: Pyrotinib;   Drug: Trastuzumab;   Drug: Docetaxel;   Drug: Carboplatin;   Drug: Placebo Oral Tablet
Sponsor:   Zhejiang Cancer Hospital
Not yet recruiting
https://ift.tt/2FKLPgo